Found: 14
Select item for more details and to access through your institution.
MYCN and HDAC2 cooperate to repress miR-183 signaling in neuroblastoma.
- Published in:
- Nucleic Acids Research, 2013, v. 41, n. 12, p. 6018, doi. 10.1093/nar/gkt346
- By:
- Publication type:
- Article
p160/SRC/NCoA coactivators form complexes via specific interaction of their PAS-B domain with the CID/AD1 domain.
- Published in:
- Nucleic Acids Research, 2008, v. 36, n. 6, p. 1847, doi. 10.1093/nar/gkn029
- By:
- Publication type:
- Article
Spatial and temporal intratumour heterogeneity has potential consequences for single biopsy-based neuroblastoma treatment decisions.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-26870-z
- By:
- Publication type:
- Article
MYCN transcriptionally represses CD9 to trigger an invasion-metastasis cascade in neuroblastoma.
- Published in:
- 2015
- By:
- Publication type:
- Abstract
Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastoma.
- Published in:
- Acta Neuropathologica Communications, 2015, v. 3, n. 1, p. 121, doi. 10.1186/s40478-015-0201-7
- By:
- Publication type:
- Article
Targeting KDM1A in Neuroblastoma with NCL-1 Induces a Less Aggressive Phenotype and Suppresses Angiogenesis.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 20, p. 6081, doi. 10.3390/jcm13206081
- By:
- Publication type:
- Article
Management of Busulfan-Induced Lung Injury in Pediatric Patients with High-Risk Neuroblastoma.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 19, p. 5995, doi. 10.3390/jcm13195995
- By:
- Publication type:
- Article
Circulating Cell-Free DNA Assessment in Biofluids from Children with Neuroblastoma Demonstrates Feasibility and Potential for Minimally Invasive Molecular Diagnostics.
- Published in:
- Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092080
- By:
- Publication type:
- Article
Nestin Expression Identifies Ependymoma Patients with Poor Outcome.
- Published in:
- Brain Pathology, 2012, v. 22, n. 6, p. 848, doi. 10.1111/j.1750-3639.2012.00600.x
- By:
- Publication type:
- Article
Inhibiting phosphoglycerate dehydrogenase counteracts chemotherapeutic efficacy against MYCN‐amplified neuroblastoma.
- Published in:
- International Journal of Cancer, 2021, v. 148, n. 5, p. 1219, doi. 10.1002/ijc.33423
- By:
- Publication type:
- Article
Reflection of neuroblastoma intratumor heterogeneity in the new OHC‐NB1 disease model.
- Published in:
- International Journal of Cancer, 2020, v. 146, n. 4, p. 1031, doi. 10.1002/ijc.32572
- By:
- Publication type:
- Article
HDAC11 is a novel drug target in carcinomas.
- Published in:
- International Journal of Cancer, 2013, v. 132, n. 9, p. 2200, doi. 10.1002/ijc.27876
- By:
- Publication type:
- Article
A novel human high-risk ependymoma stem cell model reveals the differentiation-inducing potential of the histone deacetylase inhibitor Vorinostat.
- Published in:
- Acta Neuropathologica, 2011, v. 122, n. 5, p. 637, doi. 10.1007/s00401-011-0866-3
- By:
- Publication type:
- Article
HD-MB03 is a novel Group 3 medulloblastoma model demonstrating sensitivity to histone deacetylase inhibitor treatment.
- Published in:
- Journal of Neuro-Oncology, 2012, v. 110, n. 3, p. 335, doi. 10.1007/s11060-012-0978-1
- By:
- Publication type:
- Article